The impact of pollution is blinding, but with precautions and modern technology, we can reduce its impact. From improving air ...

Eye diseases like glaucoma, cataracts, and conjunctivitis are some of the more common types. Find eye disease awareness and ...

Outlook Therapeutics reports ONS-5010 missed noninferiority endpoint in NORSE EIGHT trial for wet AMD but showed vision ...

iPSC technology provides an opportunity to study disease mechanisms and assess new treatments by engineering patient-specific retinal organoids and RPE. Human iPSCs are the source of Newcells ...

Special circumstances must be considered for plateau dwellers, such as Tibetans, mountaineers, and garrison officers, who are ...

A study by a team of Chinese researchers highlights the potential of optical coherence tomography angiography (OCTA) in ...

Image Credit: Newcells Biotech For its services, Newcells utilizes a retinal pigment epithelial (RPE) cell model comprised of a monolayer of RPE cells. Derived from healthy donor iPSCs ...

Outlook said it remains confident that ONS-5010, marketed as Lytenava in the EU, is an important therapy for the treatment of wet age-related macular degeneration in place of off-label repackaged ...

An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases.

Officials are spooked by rising cases over a horror ‘eye bleeding' disease that has spread to more than 17 countries.

The family of a girl who has an incurable eye disease are fundraising for a charity backing pioneering gene therapy which could slow down her ...

The European Commission (EC) has granted marketing authorisation for Sandoz's Afqlir, a biosimilar to the reference medicine ...